With all the hype last year I was expecting a $1 by end year. Boy did I get a reality check. Now I'm deep in the red. Luckily this is money I can afford to lose, but still bummed it didn't pan out. Still I wouldn't know where else to park my money. All the other OTCs didn't do so hot either. This one still has potential, if we're not being strung along by Henry. His track record so far leaves much to be desired. And the GBs aren't reassuring me, lol.
Market Data 
Markets 
AI
